The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review
Open accessAbstract
PURPOSE: There has been noteworthy concern about the impact of COVID-19 pandemic on health services including the management of cancer. In addition to being considered at higher risk for worse outcomes from COVID-19, people with cancer may also experience disruptions or delays in health services. This systematic review aimed to identify the delays and disruptions to cancer services globally. METHODS: This is a systematic review with a comprehensive search including specific and general databases. We considered any observational longitudinal and cross-sectional study design. The selection, data extraction, and methodological assessment were performed by two independent reviewers. The methodological quality of the studies was assessed by specific tools. The delays and disruptions identified were categorized, and their frequency was presented. RESULTS: Among the 62 studies identified, none exhibited high methodological quality. The most frequent determinants for disruptions were provider- or system-related, mainly because of the reduction in service availability. The studies identified 38 different categories of delays and disruptions with impact on treatment, diagnosis, or general health service. Delays or disruptions most investigated included reduction in routine activity of cancer services and number of cancer surgeries; delay in radiotherapy; and delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions largely affected facilities (up to 77.5%), supply chain (up to 79%), and personnel availability (up to 60%). CONCLUSION: The remarkable frequency of delays and disruptions in health care mostly related to the reduction of the COVID-19 burden unintentionally posed a major risk on cancer care worldwide. Strategies can be proposed not only to mitigate the main delays and disruptions but also to standardize their measurement and reporting. As a high number of publications continuously are being published, it is critical to harmonize the upcoming reports and constantly update this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Rayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
Yu, J., Ouyang, W., Chua, M. L. K., & Xie, C. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0980 · Cited by 1,071
Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands
Dinmohamed, A. G., Visser, O., Verhoeven, R. H. A., Louwman, M. W. J., van Nederveen, F. H., Willems, S. M., Merkx, M. A. W., Lemmens, V. E. P. P., Nagtegaal, I. D., & Siesling, S. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30265-5 · Cited by 699
Lai, A. G., Pasea, L., Banerjee, A., Hall, G., Denaxas, S., Chang, W. H., Katsoulis, M., Williams, B., Pillay, D., Noursadeghi, M., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-043828 · Cited by 447
Waterhouse, D. M., Harvey, R. D., Hurley, P., Levit, L. A., Kim, E. S., Klepin, H. D., Mileham, K. F., Nowakowski, G., Schenkel, C., Davis, C., et al. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00275 · Cited by 199
A Global Survey on the Impact of COVID-19 on Urological Services
Teoh, J. Y.-C., Ong, W. L. K., Gonzalez-Padilla, D., Castellani, D., Dubin, J. M., Esperto, F., Campi, R., Gudaru, K., Talwar, R., Okhunov, Z., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.05.025 · Cited by 173
Breast Cancer and COVID-19: The Effect of Fear on Patients' Decision-making Process
VANNI, G., MATERAZZO, M., PELLICCIARO, M., INGALLINELLA, S., RHO, M., SANTORI, F., COTESTA, M., CASPI, J., MAKAROVA, A., PISTOLESE, C. A., et al. (2020) · In Vivo · doi:10.21873/invivo.11957 · Cited by 166
Cited by
Force, L. M., Kocarnik, J. M., May, M. L., Bhangdia, K., Crist, A., Penberthy, L., Pritchett, N., Acheson, A., Deitesfeld, L., A, B., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01635-6 · Cited by 494
Global challenges and policy solutions in breast cancer control
Trapani, D., Ginsburg, O., Fadelu, T., Lin, N. U., Hassett, M., Ilbawi, A. M., Anderson, B. O., & Curigliano, G. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102339 · Cited by 316
Self-citationGaudio, E., Ammar, N., Gunturkun, F., Akkus, C., Brakefield, W., Wakefield, D. V., Pisu, M., Davis, R., Shaban-Nejad, A., & Schwartz, D. L. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.09.073 · Cited by 11
Metadata
- Authors
- Riera, R., Bagattini, Â. M., Pacheco, R. L., Pachito, D. V., Roitberg, F., & Ilbawi, A.
- Venue
- JCO Global Oncology
- Published
- 2021-12
- Volume
- 7
- Issue
- 7
- Pages
- 311-323
- ISSN
- 2687-8941 (ISSN-L)
- OpenAlex
- W3129963120
- Cited by
- 499
- References
- 47
- FWCI
- 16.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review. https://app.cochat.ai/papers/10.1200/go.20.00639
- The paper
- Riera, R., Bagattini, Â. M., Pacheco, R. L., Pachito, D. V., Roitberg, F., & Ilbawi, A. (2021). Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review. JCO Global Oncology. https://doi.org/10.1200/go.20.00639
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.